Despite market pressures, QinetiQ Group PLC (QNTQF) secures significant contracts and maintains a robust pipeline for future ...

Announced Encouraging Data on both NUC-7738 and NUC-3373 Initial Data from the Expansion Study of NUC-7738 Expected in Q4 2025 with Final Data Expected in 2026 Compliant with All Nasdaq Continued ...

Company reports Q3 2025 AUCATZYL® net product revenue of $21.1 million and deferred revenue of $7.6 million; 60 authorized treatment centers ...

Announced Encouraging Data on both NUC-7738 and NUC-3373 Initial Data from the Expansion Study of NUC-7738 Expected in Q4 2025 with Final Data ...

Investing.com -- J Sainsbury Plc (LON:SBRY) on Thursday lifted its full-year profit outlook after reporting higher first-half ...

Q3 2025 Earnings Call November 5, 2025 4:00 AM ESTCompany ParticipantsMattias Frithiof - Senior Vice President of ...

Nanoform Finland Plc | Company Release | November 12, 2025 at 08:10:00 EET Our product kernels see good momentum. Nanoenzalutamide progresses with the fed arm of the pivotal human study. Licensing and ...

Strong performance, including robust free cash flow generation and continued margin expansion, reflecting disciplined execution and operational efficiency.Marked the one-year anniversary of the POWER ...

Entered into broad strategic collaboration with Eli Lilly and Company ('Lilly”) in the area of ophthalmology, granting Lilly worldwide exclusive rights to the Company’s AAV-AIPL1 program for treatment ...

A conference call to discuss the Company's Q3 2025 operational and financial results will be held on Friday, November 7, 2025, at 8:00 a.m. PT / 11:00 a.m. ET. To participate in the conference call or ...

Net Income Attributed to Kopin Corporation for the third quarter of 2025 was $4.1 million, or $0.02 per share, compared with a net loss of ($3.5) million, or ($0.03) per share, for the Third Quarter ...

With the rise of Industry 4.0 and smart manufacturing, industrial display monitors are no longer optional—they are a key ...